The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention


Süleymanoğlu M., Rencüzoğulları İ., Karabağ Y., Çağdaş M., Yesin M., Gümüşdağ A., ...Daha Fazla

International Journal of Cardiovascular Imaging, cilt.36, sa.5, ss.789-796, 2020 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1007/s10554-019-01766-8
  • Dergi Adı: International Journal of Cardiovascular Imaging
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.789-796
  • Anahtar Kelimeler: No-reflow, Atherogenic index of plasma, St-segment elevation myocardial infarction, Percutaneous coronary intervention
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Because the phenomenon of no reflow has a poor prognosis in ST-segment elevation myocardial infarction (STEMI) patients and the atherogenic index of plasma (AIP) has been shown to be a strong predictor of coronary heart disease, we aimed to investigate the relationship between AIP and no-reflow in patients with acute STEMI who underwent primary percutaneous coronary intervention (PCI). A total of 763 consecutive STEMI patients (648 men; mean age 58 ± 12 years) who underwent primary PCI were recruited for this study. The patients were classified into a reflow group (n = 537) and a no-reflow group (n = 226) according to the postprocedural angiographic features of thrombolysis in the myocardial infarction flow of the infarct-related artery. The AIP value was significantly higher in the no-reflow group than in the reflow group [0.50 (0.38–0.65) vs. 0.39 (0.25–0.49) p <.001], and AIP was found to be an independent predictor of no-reflow development. The best cut-off value of AIP for predicting no-reflow was 0.54, with sensitivity of 46.02 and specificity of 84,73. In addition, the predictive power of AIP was greater than that of triglycerides and high-density lipoprotein cholesterol based on a receiver operator curve comparison. The AIP was independently associated with no-reflow in patients with STEMI after primary PCI. This might be a superior indicator compared to traditional lipid profiles.